The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.50
Bid: 85.00
Ask: 90.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.882%)
Open: 90.00
High: 88.00
Low: 87.50
Prev. Close: 87.50
ALK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Annual General Meeting

23 Jun 2023 12:30

RNS Number : 7637D
Alkemy Capital Investments PLC
23 June 2023
 

 

23 June 2023

 

Alkemy Capital Investments Plc

 

 

Notice of Annual General Meeting

 

Alkemy Capital Investments plc ("Alkemy") is pleased to announce that the Annual General Meeting ("AGM") of the Company will be held at Simmons & Simmons LLP, 1 Ropemaker Street, London EC2Y 9SS at 8.30 a.m. (BST) on 18 July 2023.

 

The Notice of AGM and Form of Proxy are now available for download from the Company's website at www.alkemycapital.co.uk and are being posted to all shareholders this week. 

 

Further information

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk.

 

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

VSA Capital Limited

Tel: 0203 005 5000

Shard Capital Partners LLP

Tel: 0207 186 9900

 

 

NOTES TO EDITORS

Alkemy is seeking to establish the world's leading independent and sustainable lithium hydroxide production by developing state-of-the-art lithium sulphate and lithium hydroxide facilities in Australia and the UK.

 

Alkemy, through its wholly-owned subsidiary Tees Valley Lithium, has secured a 9.6 ha brownfields site with full planning permission at the Wilton International Chemicals Park in Teesside, a major UK Freeport, to build the UK's first and Europe's largest lithium hydroxide processing facility.

 

Tees Valley Lithium has completed a Class 4 Feasibility Study for its proposed lithium hydroxide refinery which will process feedstock imported from various sources to produce 96,000 tonnes of premium, low-carbon lithium hydroxide annually, representing around 15% of Europe's projected demand.

 

Alkemy has also secured a 43 ha site near Port Hedland, Western Australia to build a world-class sustainable lithium sulphate refinery that will provide reliable feedstock for Tees Valley Lithium.

 

Forward Looking Statements

This news release contains forward‐looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward‐looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward‐looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include any factors which affect decisions as to how to develop the project, process the materials and exercise the options in respect of the lease, which may include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward‐looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.

 

The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to the transaction listed above is set out below.

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAFXLFLXQLFBBE
Date   Source Headline
26th Feb 20247:00 amRNSChange of Adviser
30th Jan 20247:00 amRNSMOU with Syrah for UK’s first Graphite refinery
18th Jan 20247:00 amRNSCorporate Update
18th Dec 20237:00 amRNSOversubscribed Placing to raise £650,000
4th Dec 20237:00 amRNSTVL Secures Technology and Vendor Partnerships
20th Nov 20237:00 amRNSAppointment of Battery Metals Supply Chain Expert
13th Nov 20237:00 amRNSTVL First Feedstock Deal
1st Nov 202311:20 amRNSCorporate Presentation
31st Oct 202311:00 amRNSInvestor Webinar
27th Oct 20238:00 amRNSInterim Results for Period Ended 31 July 2023
24th Oct 20237:00 amRNSVSA lifts target price to £15.30 per share
3rd Oct 20237:00 amRNSUpdate on Lithium Feedstock and Offtake
29th Sep 20237:00 amRNSTVL Grant Funding Secured
23rd Aug 20238:00 amRNSFirst Lithium Sulphate Plant Study
1st Aug 202310:00 amRNSAustralia’s first Lithium Sulphate Plant
18th Jul 202311:00 amRNSResult of AGM
5th Jul 202311:00 amRNSAppointment of SI Capital as Corporate Broker
23rd Jun 202312:30 pmRNSNotice of Annual General Meeting
6th Jun 20234:00 pmRNSGrant of Options
31st May 20238:00 amRNS£1.35m Fundraise and Director Participation
31st May 20237:55 amRNSAnnual Report & Financial Statements
12th May 20238:00 amRNSMOU on process to unlock major Lithium feedstock
28th Apr 20238:00 amRNSTVL Management Recruitment
26th Apr 20238:00 amRNSMOU with Altilium Metals for lithium feedstock
20th Apr 20238:00 amRNSCorporate Update
17th Apr 20237:00 amRNSUK Minister Port Hedland Site Visit
31st Mar 20234:35 pmRNSPrice Monitoring Extension
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20237:00 amRNSCMA highlights TVL’s strategic importance
1st Mar 20237:00 amRNSTVL Accelerates Lithium Supply With BritishVolt
7th Feb 20237:00 amRNSMOU with Recharge Industries
24th Jan 20237:00 amRNSFirst phase approval from the UK ATF
19th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSSite secured for Port Hedland Lithium plant
20th Dec 20227:00 amRNSLong Term Lease Agreed for TVL’s Lithium Facility
5th Dec 20229:00 amRNSCorporate Presentation
25th Nov 20227:00 amRNSApproval for Europe's biggest Lithium Plant
8th Nov 20227:00 amRNSAppointment of Lead Engineering Partner
27th Oct 20227:00 amRNSInterim Results
12th Oct 20229:30 amRNSTVL and bp trial Green Hydrogen
29th Sep 20227:00 amRNSCorporate Update
23rd Aug 20228:45 amRNSInitiation of Research Report by Shard Capital
15th Aug 20227:00 amRNSAgreement with Weardale Lithium
12th Aug 20225:00 pmRNSHolding(s) in Company
8th Aug 20223:20 pmRNSCorrection: Placing and Directors Purchase
8th Aug 20227:00 amRNSAustralia’s First Lithium Sulphate Plant
4th Aug 20228:00 amRNSGrant of Options
4th Aug 20227:00 amRNSOversubscribed Placing and Director Purchase
21st Jul 20227:00 amRNSLithium Feedstock Agreement with Traxys

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.